JP7398589B1 - External pain relief preparation containing ginger ingredients - Google Patents
External pain relief preparation containing ginger ingredients Download PDFInfo
- Publication number
- JP7398589B1 JP7398589B1 JP2023087352A JP2023087352A JP7398589B1 JP 7398589 B1 JP7398589 B1 JP 7398589B1 JP 2023087352 A JP2023087352 A JP 2023087352A JP 2023087352 A JP2023087352 A JP 2023087352A JP 7398589 B1 JP7398589 B1 JP 7398589B1
- Authority
- JP
- Japan
- Prior art keywords
- oil
- extract
- external preparation
- ginger
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- 235000006886 Zingiber officinale Nutrition 0.000 title claims abstract description 47
- 235000008397 ginger Nutrition 0.000 title claims abstract description 47
- 241000234314 Zingiber Species 0.000 title claims abstract description 45
- 208000002193 Pain Diseases 0.000 title claims abstract description 14
- 239000004615 ingredient Substances 0.000 title description 9
- 239000000284 extract Substances 0.000 claims abstract description 60
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 claims abstract description 20
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 claims abstract description 20
- 239000006071 cream Substances 0.000 claims abstract description 6
- 235000011803 sesame oil Nutrition 0.000 claims description 18
- 239000008159 sesame oil Substances 0.000 claims description 18
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 10
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 10
- 229940057910 shea butter Drugs 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 230000000699 topical effect Effects 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract description 15
- 239000008158 vegetable oil Substances 0.000 abstract description 15
- 229940002508 ginger extract Drugs 0.000 abstract description 6
- 235000020708 ginger extract Nutrition 0.000 abstract description 6
- 206010040880 Skin irritation Diseases 0.000 abstract description 3
- 208000004296 neuralgia Diseases 0.000 abstract description 3
- 208000021722 neuropathic pain Diseases 0.000 abstract description 3
- 230000036556 skin irritation Effects 0.000 abstract description 3
- 231100000475 skin irritation Toxicity 0.000 abstract description 3
- 230000035807 sensation Effects 0.000 abstract description 2
- 238000010586 diagram Methods 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 239000000341 volatile oil Substances 0.000 description 21
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- -1 etc. Substances 0.000 description 18
- 235000019645 odor Nutrition 0.000 description 18
- 238000000605 extraction Methods 0.000 description 15
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 229940098465 tincture Drugs 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 239000002994 raw material Substances 0.000 description 11
- 239000000419 plant extract Substances 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 9
- 239000010774 macerated oil Substances 0.000 description 8
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 8
- 229940032094 squalane Drugs 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 235000013871 bee wax Nutrition 0.000 description 7
- 239000012166 beeswax Substances 0.000 description 7
- 229940092738 beeswax Drugs 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 235000013311 vegetables Nutrition 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- 239000004166 Lanolin Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 235000019388 lanolin Nutrition 0.000 description 5
- 229940039717 lanolin Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 229930003799 tocopherol Natural products 0.000 description 5
- 235000010384 tocopherol Nutrition 0.000 description 5
- 229960001295 tocopherol Drugs 0.000 description 5
- 239000011732 tocopherol Substances 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 4
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 4
- 235000003880 Calendula Nutrition 0.000 description 4
- 240000001432 Calendula officinalis Species 0.000 description 4
- 239000004264 Petrolatum Substances 0.000 description 4
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- 229940066842 petrolatum Drugs 0.000 description 4
- 235000019271 petrolatum Nutrition 0.000 description 4
- 229940031439 squalene Drugs 0.000 description 4
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000008168 almond oil Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000008169 grapeseed oil Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000019487 Hazelnut oil Nutrition 0.000 description 2
- 240000003553 Leptospermum scoparium Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 2
- 235000019774 Rice Bran oil Nutrition 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000010478 argan oil Substances 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 229940082483 carnauba wax Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940124579 cold medicine Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000010468 hazelnut oil Substances 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- SIOLDWZBFABPJU-UHFFFAOYSA-N isotridecanoic acid Chemical compound CC(C)CCCCCCCCCC(O)=O SIOLDWZBFABPJU-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000008165 rice bran oil Substances 0.000 description 2
- 239000004170 rice bran wax Substances 0.000 description 2
- 235000019384 rice bran wax Nutrition 0.000 description 2
- 239000010667 rosehip oil Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- QOOJEEZYYXGPAO-UHFFFAOYSA-N 2,2-bis(2-ethylhexanoyloxymethyl)butyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(CC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC QOOJEEZYYXGPAO-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- XFBOJHLYDJZYSP-UHFFFAOYSA-N 2,8-dioxoadenine Chemical compound N1C(=O)N=C2NC(=O)NC2=C1N XFBOJHLYDJZYSP-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- WADQOGCINABPRT-UHFFFAOYSA-N 3-chloro-2-methylphenol Chemical compound CC1=C(O)C=CC=C1Cl WADQOGCINABPRT-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 244000294263 Arctium minus Species 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- SGPMPZKXUXPIBJ-UHFFFAOYSA-N C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC Chemical compound C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC SGPMPZKXUXPIBJ-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 241000384508 Hoplostethus atlanticus Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000013939 Malva Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000004429 Matricaria chamomilla var recutita Nutrition 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940082880 azadirachta indica flower extract Drugs 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DMMXZLMYEUEJFT-UHFFFAOYSA-N ethyl 16-methylheptadecanoate Chemical compound CCOC(=O)CCCCCCCCCCCCCCC(C)C DMMXZLMYEUEJFT-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 150000005165 hydroxybenzoic acids Chemical class 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229940083980 lavender extract Drugs 0.000 description 1
- 235000020723 lavender extract Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002018 neem oil Substances 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- PIUVNPNBPWVVKZ-UHFFFAOYSA-N octadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC PIUVNPNBPWVVKZ-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940093609 tricaprylin Drugs 0.000 description 1
- 229940113164 trimyristin Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229940026256 trioctyldodecyl citrate Drugs 0.000 description 1
- BIEMOBPNIWQLMF-UHFFFAOYSA-N tris(2-octyldodecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CC(O)(C(=O)OCC(CCCCCCCC)CCCCCCCCCC)CC(=O)OCC(CCCCCCCC)CCCCCCCCCC BIEMOBPNIWQLMF-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
【課題】本発明は臭気と皮膚刺激性の少ないショウガ抽出物を作成し、それを用いた疼痛緩和用外用剤を提供するものである。【解決手段】本発明は、乾燥させたショウガ(乾姜)を植物油で抽出した抽出液を50重量%以上含む外用剤であって、6-ショウガオールを10~200ppm含有することを特徴とする外用剤である。臭気や皮膚刺激性が少なく、ローションやクリーム剤として外用することで特に神経障害性疼痛や冷感の緩和に好適に使用できる。【選択図】図1[Problem] The present invention prepares a ginger extract with low odor and skin irritation, and provides an external preparation for pain relief using the ginger extract. [Solution] The present invention is an external preparation containing 50% by weight or more of an extract obtained by extracting dried ginger (dried ginger) with vegetable oil, and is characterized by containing 10 to 200 ppm of 6-shogaol. It is an external preparation. It has little odor and skin irritation, and when used externally as a lotion or cream, it can be used particularly to alleviate neuropathic pain and cold sensations. [Selection diagram] Figure 1
Description
本発明は、ショウガ成分を含有する疼痛緩和のための外用剤に関するものである。 The present invention relates to an external preparation for pain relief containing a ginger component.
ショウガは古くから食用の他、風邪薬、健胃消化薬、鎮吐薬、鎮痛薬などとして漢方薬に配合されている。内服時の発熱、発汗作用、抗炎症作用等は良く知られており、風邪薬や健康食品等にも応用されている。これらの作用のうち、抗炎症作用については現在まで分子生物学的な機序はハッキリしていなかったが、近年6-ショウガオールに神経細胞を酸化ストレスから保護する作用があることが報告されており(非特許文献1)、そのような保護作用による作用の可能性が示された。ショウガを用いた外用剤も開発されているが一般的ではなく、血流改善による皮膚の老化防止や、保湿機能の向上などが期待されている程度である(特許文献1)。 Since ancient times, ginger has been used not only as a food but also in Chinese herbal medicine as a cold medicine, digestive aid, antiemetic, and analgesic. It is well known for its antipyretic, sweating, and anti-inflammatory effects when taken internally, and is also used in cold medicines and health foods. Among these effects, the molecular biological mechanism of its anti-inflammatory effect has not been clearly defined until now, but in recent years it has been reported that 6-shogaol has the effect of protecting nerve cells from oxidative stress. (Non-Patent Document 1), the possibility of such a protective action was demonstrated. Although external preparations using ginger have been developed, they are not common and are only expected to prevent skin aging by improving blood flow and improve moisturizing function (Patent Document 1).
ショウガの抽出方法としては、他の植物由来の抽出物と同様、有機溶媒による抽出か水蒸気蒸留が一般的である。一般的なショウガエキスと呼ばれるものは、エタノール等の親水性有機溶媒で生または乾燥したショウガの根茎を抽出し、それを濃縮したものである。ショウガのエッセンシャルオイルとして販売されているものは、ショウガの根茎を水蒸気蒸留して得られる精油である。これらの抽出物は非常に強い刺激臭を持つという特徴がある。ショウガにはシネオールやジンギベレン等の臭気のある成分が含まれており、これらはアルコール可溶性であり低沸点な化合物である。したがって、一般的な抽出方法ではこれらの臭気成分が濃縮されてしまい、必然的に刺激臭が強くなってしまうという欠点があった。 As with other plant-derived extracts, ginger is generally extracted using organic solvents or steam distillation. What is commonly called ginger extract is extracted from fresh or dried ginger rhizomes using a hydrophilic organic solvent such as ethanol, and then concentrated. Ginger essential oil is obtained by steam distillation of ginger rhizomes. These extracts are characterized by a very strong pungent odor. Ginger contains odorous components such as cineole and zingiberene, which are alcohol-soluble and low-boiling compounds. Therefore, the conventional extraction method has the disadvantage that these odor components are concentrated and the pungent odor inevitably becomes stronger.
一方、我々は尋常性白斑の治療薬を探索する過程で、ショウガのゴマ油抽出物を発見したが(特許文献2)、この抽出物には従来の抽出物にあるような刺激臭はなかった。尋常性白斑の改善の機序は、ショウガの含有成分の1つである6-ショウガオールがメラノサイトを酸化ストレスから保護する作用が一因であると推定されている(非特許文献2)。メラノサイトと神経細胞は類似の細胞であるため、このような細胞をストレスから保護する作用は、神経の炎症抑制や疼痛緩和にも効果があると考え検討することとした。疼痛緩和用の外用剤としては、ケトプロフェンやイブプロフェンなど多種の有効成分が知られているが、帯状疱疹後神経痛などの神経障害性疼痛に関しては、今でも有効な鎮痛外用剤というものは少ないため、アンメットニーズが少なからず存在する。
On the other hand, in the process of searching for a therapeutic agent for vitiligo vulgaris, we discovered a sesame oil extract of ginger (Patent Document 2), but this extract did not have the irritating odor that conventional extracts have. The mechanism of improvement in vitiligo vulgaris is presumed to be due in part to the effect of 6-shogaol, one of the ingredients in ginger, protecting melanocytes from oxidative stress (Non-Patent Document 2). Since melanocytes and nerve cells are similar cells, we decided to investigate the idea that the effect of protecting these cells from stress could also be effective in suppressing nerve inflammation and alleviating pain. Various active ingredients such as ketoprofen and ibuprofen are known for topical pain relief, but there are still few effective topical analgesics for neuropathic pain such as postherpetic neuralgia. There are quite a few unmet needs.
本発明は臭気や皮膚刺激性の少ないショウガ抽出物を作成し、それを用いた疼痛緩和用外用剤を提供するものである。 The present invention creates a ginger extract with low odor and skin irritation, and provides an external preparation for pain relief using the ginger extract.
本発明者は鋭意研究を重ねたところ、植物油を用いて乾燥させたショウガを抽出することにより、臭気や刺激性の少ない抽出物を得ることができ、外用剤に好適に使用できることを見出した。これはショウガの臭気の元である化合物の多くが親水性であるため抽出されにくく、かつ植物油の沸点が高いことにより、混合蒸気による臭気成分の拡散が起こりにくいことが理由であると考えられる。
本発明は、当該知見に基づいて完成されたものであり、以下の態様を含む。
項1.乾燥させたショウガ(乾姜)粉末を非焙煎ゴマ油を用いて抽出し、抽出後の乾姜粉末をろ過によって除去することを特徴とする抽出液を、50重量%以上含む外用剤であって、6-ショウガオールを10~200ppm含有することを特徴とする疼痛緩和用外用剤
項2.請求項1に記載の外用剤であって、シアバターを含むことを特徴とする外用クリーム剤
After extensive research, the present inventor discovered that by extracting dried ginger using vegetable oil, an extract with less odor and irritation can be obtained, and can be suitably used in external preparations. This is thought to be because many of the compounds that cause ginger's odor are hydrophilic and therefore difficult to extract, and the high boiling point of vegetable oils makes it difficult for odor components to diffuse through mixed steam.
The present invention was completed based on this knowledge and includes the following aspects.
本発明によれば、臭気の少ないショウガ成分含有外用剤を得ることができ、神経障害性の疼痛緩和等の目的に好適に使用できる。 According to the present invention, a ginger component-containing external preparation with little odor can be obtained, and can be suitably used for the purpose of alleviating neuropathic pain.
1.外用剤
本発明にかかる外用剤は、乾燥させたショウガ(乾姜)を、植物油を用いて抽出した抽出液を含む。抽出原料には抽出効率や保存安定性の観点から乾姜の乾燥粉末を用いることが好ましい。乾姜の乾燥粉末については、国内の漢方薬局から容易に調達することが可能である。
1. External preparation The external preparation according to the present invention contains an extract obtained by extracting dried ginger using vegetable oil. From the viewpoint of extraction efficiency and storage stability, it is preferable to use dried ginger powder as the extraction raw material. Dried ginger powder can be easily procured from domestic Chinese herbal pharmacies.
抽出のための溶媒は、植物油であれば特に制限されない。例えば、オリーブオイル、グレープシードオイル、ゴマ油等が挙げられるが、皮膚との親和性や品質面での安定性、凝固点の点からゴマ油が好ましい。ゴマ油としては、制限されないが、焙煎していないゴマ油を使用することが好ましい。焙煎したゴマ油は、加熱(150℃~220℃程度)や脱臭の加工により成分が変性してしまうため、可能な限り搾油後の処置をしない油を選択するのが好ましい。 The solvent for extraction is not particularly limited as long as it is a vegetable oil. Examples include olive oil, grapeseed oil, sesame oil, etc., and sesame oil is preferred from the viewpoint of affinity with the skin, stability in terms of quality, and solidification point. Although the sesame oil is not limited, it is preferable to use unroasted sesame oil. Since the components of roasted sesame oil are denatured by heating (approximately 150°C to 220°C) and deodorizing processes, it is preferable to select an oil that is not subjected to post-extraction treatment as much as possible.
本発明においては、抽出操作を行う前に、使用する植物油を80~130℃で10~30分程度加熱処理するのが好ましい。この処理により、刺激性のある揮発分を除去できることが期待される。 In the present invention, the vegetable oil used is preferably heat-treated at 80 to 130° C. for about 10 to 30 minutes before performing the extraction operation. This treatment is expected to remove irritating volatile components.
本発明の抽出液は、植物油に乾姜を浸漬し、30分~24時間程度、好ましくは6~8時間程度、常温(15℃~35℃程度)で放置し、その後、濾過により固形物を除去して液層を回収することにより得ることができる。抽出時の乾姜と植物油の比率は、乾姜1重量部に対して植物油10~100重量部に調整することが好ましい。 The extract of the present invention is prepared by soaking dried ginger in vegetable oil, leaving it at room temperature (about 15°C to 35°C) for about 30 minutes to 24 hours, preferably about 6 to 8 hours, and then filtering it to remove solids. It can be obtained by removing the liquid layer and collecting the liquid layer. The ratio of dried ginger and vegetable oil during extraction is preferably adjusted to 10 to 100 parts by weight of vegetable oil per 1 part by weight of dried ginger.
抽出液中における乾姜から抽出される成分の濃度は、抽出時の乾姜と植物油の量比と正の相関があるが、一般的には溶質の比率が溶媒に対して大きくなりすぎると、溶質側に残留する割合が大きくなるため抽出効率が低下する。上記の量比が小さすぎると成分の抽出量が少なすぎて有効成分濃度が薄くなり、大きすぎても抽出効率の低下によって有効成分がそれほど抽出されなくなるため、その量比は1:10~100程度とするのが好ましい。 The concentration of components extracted from dried ginger in the extract has a positive correlation with the ratio of dried ginger to vegetable oil at the time of extraction, but in general, if the ratio of solute to solvent becomes too large, Since the proportion remaining on the solute side increases, the extraction efficiency decreases. If the above quantitative ratio is too small, the amount of ingredients extracted will be too small and the concentration of the active ingredient will be diluted, and if it is too large, the extraction efficiency will decrease and the effective ingredient will not be extracted as much, so the quantitative ratio should be 1:10 to 100. It is preferable to set it as approximately.
抽出される成分のすべてを管理することは技術的に困難であるため、有効性の指標となる化合物濃度を代表値として管理することが好ましい。抽出液中の濃度の指標として6-ショウガオールを代表値とする場合、その濃度は10ppm以上、200ppm以下とすることが好ましい。6-ショウガオールの濃度は原料となる乾姜に含まれる量および抽出時の植物油との量比に依存するため、原料ごとの管理が必要となる。また本発明の抽出方法においては、溶剤の揮発による濃縮が技術的に困難であるため、抽出液に含まれる6-ショウガオールの濃度には上限がある。実験により求めた乾姜と一般的な植物油間での6-ショウガオールの分配係数と、乾姜に含まれる6-ショウガオールの文献値を参照して検討を行ったところ、本発明の抽出方法によって200ppmを超える6-ショウガオールを抽出するのは技術的に困難であった。 Since it is technically difficult to control all extracted components, it is preferable to control the compound concentration, which is an indicator of effectiveness, as a representative value. When using 6-shogaol as a representative value as an indicator of the concentration in the extract, the concentration is preferably 10 ppm or more and 200 ppm or less. The concentration of 6-shogaol depends on the amount contained in dried ginger, which is the raw material, and the ratio of the amount to the vegetable oil at the time of extraction, so it is necessary to manage each raw material. Furthermore, in the extraction method of the present invention, there is an upper limit to the concentration of 6-shogaol contained in the extract because it is technically difficult to concentrate by evaporating the solvent. After conducting a study with reference to the experimentally determined distribution coefficient of 6-shogaol between dried ginger and common vegetable oils and literature values for 6-shogaol contained in dried ginger, the extraction method of the present invention was found. It was technically difficult to extract more than 200 ppm of 6-shogaol.
前述しているように、6-ショウガオールには神経細胞を酸化ストレス等の障害から保護する作用が報告されており、帯状疱疹後神経痛や関節痛のように神経細胞そのものや近縁の細胞の炎症によって生じる神経組織へのストレスを軽減し、疼痛を緩和する作用が期待される。上記の濃度範囲において個人差はあるものの疼痛緩和の効果が得られる。 As mentioned above, 6-shogaol has been reported to have the effect of protecting nerve cells from disorders such as oxidative stress, and it has been reported that 6-shogaol has the effect of protecting nerve cells from damage such as oxidative stress, and can cause damage to nerve cells themselves and related cells, such as in postherpetic neuralgia and arthralgia. It is expected to reduce stress on nerve tissue caused by inflammation and alleviate pain. Within the above concentration range, pain relief effects can be obtained although there are individual differences.
例えば植物油やエタノールなどのキャリアに、6-ショウガオールを含有するアルコール抽出物やエッセンシャルオイルを混合することにより、同様の組成物を得ることは可能であるが、これらの抽出物やエッセンシャルオイルには臭気成分を含む刺激成分が多く含まれているため、非常に皮膚刺激の強い組成物となってしまい実用に耐えないものとなる。このような理由のため、本発明の外用剤は乾姜を植物油で直接抽出して外用剤を得る。 For example, it is possible to obtain a similar composition by mixing an alcoholic extract or essential oil containing 6-shogaol with a carrier such as vegetable oil or ethanol, but these extracts and essential oils contain odor components. Since it contains many irritating ingredients including , the composition becomes extremely irritating to the skin and cannot be put to practical use. For this reason, the external preparation of the present invention is obtained by directly extracting dried ginger with vegetable oil.
本発明の外用剤は、上記抽出液を希釈せずに用いるか、上記の抽出液を下記基剤原料と混合することにより調製することができる。本発明の外用剤の剤形として、クリーム、液剤を挙げることができる。好ましくは油性クリーム剤である。 The external preparation of the present invention can be prepared by using the above-mentioned extract without diluting or by mixing the above-mentioned extract with the following base material. The dosage forms of the external preparation of the present invention include creams and liquid preparations. Preferably it is an oily cream.
基剤原料は、疎水性であることが好ましい。本発明の外用剤は、ゴマ油によって有効成分の皮膚内への浸透が促進されることが期待される。また、疎水性基剤よって有効成分が皮膚のバリア機能を通過しやすくなることが期待される。このため、これらの作用を妨げないよう、本発明の外用剤には、過剰な水分や水分と疎水性の基剤原料を乳化させるような界面活性剤は用いないことが好ましい。 The base raw material is preferably hydrophobic. In the external preparation of the present invention, sesame oil is expected to promote the penetration of the active ingredient into the skin. It is also expected that the hydrophobic base will allow the active ingredient to more easily pass through the skin's barrier function. Therefore, in order not to interfere with these effects, it is preferable that the external preparation of the present invention does not contain excess water or a surfactant that emulsifies the water and the hydrophobic base material.
本発明の外用剤の基剤原料は、医薬品、医薬部外品及び化粧品を調製するために使用されるものであれば特に制限されない。 The base raw material for the external preparation of the present invention is not particularly limited as long as it is used for preparing pharmaceuticals, quasi-drugs, and cosmetics.
基剤原料としては、油脂類(アボガドオイル、ツバキ油、米ぬか油、サフラワーオイル、大豆油、コーン油、ナタネ油、杏仁油、パーシック油、ヒマワリ油、桃仁油、コットンシードオイル、ココナッツ油、小麦胚芽油、米胚芽油、月見草油、ハイブリットヒマワリ油、マカデミアナッツオイル、メドウファームオイル、ヘーゼルナッツオイル、オリーブオイル、ひまし油、ゴマ油、アーモンドオイル、グレープシードオイル、シアバター、パーム核油、パーム油、ヤシ油、カカオ脂、木ロウ、アルガンオイル、ローズヒップオイル、ミンク油、タートル油、卵黄油、牛脂、乳脂、豚脂、馬油等)、炭化水素類(植物性スクワレン、植物性スクワラン、ワセリン、マイクロクリスタリンワセリン、スクワレン、スクワラン、流動パラフィン、パラフィン、軟質イソパラフィン、流動イソパラフィン、流動ポリイソブチレン、水添ポリイソブチレン、オゾケライト、セレシン、合成スクワラン、α-オレフィンオリゴマー、ポリブテン、ポリエチレン等)、脂肪酸エステル類(ミリスチン酸イソプロピル、パルミチン酸イソプロピル、ステアリン酸ブチル、オレイン酸エチル、パルミチン酸セチル、ミリスチン酸ミリスチル、ミスチリン酸オクチルドデシル、オレイン酸オクチルドデシル、ステアリン酸コレステリル、ヒドロキシステアリン酸コレステリル、トリカプリリン、トリミリスチン、トリオクタノイン、イソステアリン酸イソプロピル、イソステアリン酸エチル、エチルヘキサン酸セチル、エチルヘキサン酸ステアリル、トリエチルヘキサン酸グリセリル、トリエチルヘキサン酸トリメチロールプロパン等、テトラエチルヘキサン酸ペンタエリスリチル、トリイソステアリン酸グリセリル、トリイソステアリン酸トリメチロールプロパン、テトライソステアリン酸ペンタエリスリチル、イソステアリン酸イソセチル、ジメチルオクタン酸オクチルドデシル、乳酸ミリスチル、乳酸セチル、クエン酸トリオクチルドデシル、リンゴ酸ジイソステアリル等)、ロウ類(ミツロウ、ラノリン、還元ラノリン、ホホバ油、カルナウバロウ、キャンデリラロウ、米ぬかロウ、オレンジラフィー油、セラック、モンタンロウ等)、高級脂肪酸(ラウリル酸、ステアリン酸、ミリスチン酸、パルミチン酸、ベヘン酸、オレイン酸、リノール酸、エチルヘキサン酸、イソステアリン酸、イソパルミチン酸、イソトリデカン酸、イソノナン酸、ペンタデカン酸等)、高級アルコール(ラウリルアルコール、ステアリルアルコール、セテアリルアルコール、ベヘニルアルコール、オレイルアルコール、ラノリンアルコール、セタノール、コレステロール、イソコレステロール、シトステロール、スチグマステロール、イソステアリルアルコール、オクチルドデカノール、ヘキシルデカノール等)、シリコーンオイル等が挙げられる。 Base raw materials include oils and fats (avocado oil, camellia oil, rice bran oil, safflower oil, soybean oil, corn oil, rapeseed oil, apricot kernel oil, persic oil, sunflower oil, peach kernel oil, cottonseed oil, coconut oil, Wheat germ oil, rice germ oil, evening primrose oil, hybrid sunflower oil, macadamia nut oil, meadow farm oil, hazelnut oil, olive oil, castor oil, sesame oil, almond oil, grapeseed oil, shea butter, palm kernel oil, palm oil, coconut Oil, cacao butter, wood wax, argan oil, rosehip oil, mink oil, turtle oil, egg yolk oil, beef tallow, milk fat, lard, horse oil, etc.), hydrocarbons (vegetable squalene, vegetable squalane, petrolatum, Microcrystalline petrolatum, squalene, squalane, liquid paraffin, paraffin, soft isoparaffin, liquid isoparaffin, liquid polyisobutylene, hydrogenated polyisobutylene, ozokerite, ceresin, synthetic squalane, α-olefin oligomer, polybutene, polyethylene, etc.), fatty acid esters ( Isopropyl myristate, isopropyl palmitate, butyl stearate, ethyl oleate, cetyl palmitate, myristyl myristate, octyldodecyl mystilate, octyldodecyl oleate, cholesteryl stearate, cholesteryl hydroxystearate, tricaprylin, trimyristin, trio Cutanoin, isopropyl isostearate, ethyl isostearate, cetyl ethylhexanoate, stearyl ethylhexanoate, glyceryl triethylhexanoate, trimethylolpropane triethylhexanoate, etc., pentaerythrityl tetraethylhexanoate, glyceryl triisostearate, triisostearate Methylolpropane, pentaerythrityl tetraisostearate, isocetyl isostearate, octyldodecyl dimethyloctanoate, myristyl lactate, cetyl lactate, trioctyldodecyl citrate, diisostearyl malate, etc.), waxes (beeswax, lanolin, reduced lanolin, Jojoba oil, carnauba wax, candelilla wax, rice bran wax, orange roughy oil, shellac, montan wax, etc.), higher fatty acids (lauric acid, stearic acid, myristic acid, palmitic acid, behenic acid, oleic acid, linoleic acid, ethylhexanoic acid, isostearic acid, isopalmitic acid, isotridecanoic acid, isononanoic acid, pentadecanoic acid, etc.), higher alcohols (lauryl alcohol, stearyl alcohol, cetearyl alcohol, behenyl alcohol, oleyl alcohol, lanolin alcohol, cetanol, cholesterol, isocholesterol, sitosterol, stigma) sterol, isostearyl alcohol, octyldodecanol, hexyldecanol, etc.), silicone oil, etc.
基剤原料として好ましくは、油脂類(アボガドオイル、ツバキ油、米ぬか油、マカデミアナッツオイル、ヘーゼルナッツオイル、オリーブオイル、ひまし油、ゴマ油、アーモンドオイル、グレープシードオイル、シアバター、パーム核油、パーム油、ヤシ油、カカオ脂、木ロウ、アルガンオイル、ローズヒップオイル)、炭化水素類(植物性スクワレン、植物性スクワラン、ワセリン、マイクロクリスタリンワセリン、スクワレン、スクワラン、合成スクワラン)、及びロウ類(ミツロウ、ラノリン、還元ラノリン、ホホバ油、カルナウバロウ、キャンデリラロウ、米ぬかロウ)からなる群から選択される少なくとも一種である。基剤原料としてより好ましくは、ゴマ油、スイートアーモンドオイル、植物性スクワラン、スクワラン、ワセリン、ミツロウ、シアバター、ホホバ油等である。基剤原料としてさらに好ましくはシアバターである。シアバターの軟化点は体温に近いため、混合物が非常に肌になじみやすく好適である。 Preferred base materials include oils and fats (avocado oil, camellia oil, rice bran oil, macadamia nut oil, hazelnut oil, olive oil, castor oil, sesame oil, almond oil, grapeseed oil, shea butter, palm kernel oil, palm oil, coconut oil). oil, cacao butter, wood wax, argan oil, rosehip oil), hydrocarbons (vegetable squalene, vegetable squalane, petrolatum, microcrystalline petrolatum, squalene, squalane, synthetic squalane), and waxes (beeswax, lanolin, The wax is at least one selected from the group consisting of reduced lanolin, jojoba oil, carnauba wax, candelilla wax, and rice bran wax. More preferred base materials include sesame oil, sweet almond oil, vegetable squalane, squalane, vaseline, beeswax, shea butter, and jojoba oil. More preferred as the base raw material is shea butter. Since the softening point of shea butter is close to body temperature, the mixture blends well with the skin and is suitable.
抽出液を基剤原料で希釈する場合には、前記抽出液の含有量は、外用剤全体の量を100重量%とした場合、50~80重量%の範囲で含まれればよい。希釈の目的はクリーム状とするための増粘であり、シアバターやミツロウのような固形成分を20~50重量%含有させることで、目的とする粘度・軟化点の外用剤を調整することが可能となる。 When the extract is diluted with a base raw material, the content of the extract may be in the range of 50 to 80% by weight when the total amount of the external preparation is 100% by weight. The purpose of dilution is to increase the viscosity to make it creamy, and by including 20 to 50% by weight of solid ingredients such as shea butter and beeswax, it is possible to adjust the desired viscosity and softening point of the external preparation. It becomes possible.
本発明の外用剤は植物油がベースとなっているため、抗酸化剤であるビタミンE化合物を含むことが好ましい。ビタミンE化合物としては、トコフェロール、酢酸トコフェロール、トコフェリン、酢酸トコフェリン等を挙げることができる。ビタミンE化合物の含有量は、外用剤全体の量を100重量%とした場合、同成分が0.01~5重量%の範囲で含まれればよい。 Since the external preparation of the present invention is based on vegetable oil, it preferably contains a vitamin E compound, which is an antioxidant. Examples of the vitamin E compound include tocopherol, tocopherol acetate, tocopherin, and tocopherin acetate. The content of the vitamin E compound may be within the range of 0.01 to 5% by weight when the total amount of the external preparation is 100% by weight.
本発明の外用剤は、抗炎症効果、抗菌効果、抗真菌効果、創傷治癒効果、肌荒れ防止効果、皮脂分泌抑制効果等を有するショウガ以外の植物抽出物(精油、浸出油、乾燥エキス等)、殺菌剤、防腐剤、酸化防止剤等の添加剤を含んでいてもよい。 The external preparation of the present invention includes plant extracts other than ginger (essential oils, infused oils, dry extracts, etc.) that have anti-inflammatory effects, antibacterial effects, antifungal effects, wound healing effects, skin roughness prevention effects, sebum secretion suppressing effects, etc. It may also contain additives such as bactericides, preservatives, and antioxidants.
乾姜以外の植物抽出物としては、カレンデュラ抽出物(花の精油、浸出油、チンキ、エキス等)、アルニカ抽出物(花の浸出油等)、セージ抽出物(葉の精油、浸出油、チンキ、エキス等)、ローズマリー抽出物(葉の精油、浸出油、チンキ、エキス等)、ティートリー抽出物(葉の精油等)、ニーム抽出物(実の核から圧搾機で絞ったニームオイル等)、バードック抽出物(根の浸出油、エキス等)、ユーカリ抽出物(葉の精油等)、ラベンダー抽出物(花の精油、チンキ、エキス、芳香蒸留水等)、レモンバーム抽出物(葉の精油等)、ドクダミ抽出物(葉のチンキ、エキス等)、ハトムギ抽出物(実のエキス、チンキ等)、ヒース抽出物(花のエキス、チンキ等)、エキセアナ抽出物(全草のチンキ、エキス等)、ウスベニアオイ抽出物(花又は葉のエキス、チンキ等)、ジャーマンカモミール(抽出物花の精油、チンキ、エキス等)、マシュマロウ抽出物(根又は葉のエキス等)、ヤロー抽出物(花の精油、エキス、チンキ等)を挙げることができる。好ましくは、カレンデュラ抽出物(特にカレンデュラオイル)、ティートリー抽出物(葉の精油)、ドクダミ抽出物(特に葉のチンキ、エキス)、ハトムギ抽出物(実のエキス、チンキ等)であり、特に好ましくはカレンデュラオイルである。有効成分濃度を調整する目的で、少量のジンジャー抽出エキスの添加は可能である。 Plant extracts other than dried ginger include calendula extract (flower essential oil, infused oil, tincture, extract, etc.), arnica extract (flower infused oil, etc.), sage extract (leaf essential oil, infused oil, tincture, etc.) , extract, etc.), rosemary extract (leaf essential oil, infused oil, tincture, extract, etc.), tea tree extract (leaf essential oil, etc.), neem extract (neem oil squeezed from the core of the fruit using a press) , Burdock extract (root infusion oil, extract, etc.), Eucalyptus extract (leaf essential oil, etc.), Lavender extract (flower essential oil, tincture, extract, aromatic distilled water, etc.), Lemon balm extract (leaf essential oil, etc.) ), Heutyami extract (leaf tincture, extract, etc.), Coix barley extract (fruit extract, tincture, etc.), Heath extract (flower extract, tincture, etc.), Exeana extract (whole plant tincture, extract, etc.) , Malva extract (flower or leaf extract, tincture, etc.), German chamomile (flower essential oil extract, tincture, extract, etc.), Marshmallow extract (root or leaf extract, etc.), Yarrow extract (flower essential oil) , extract, tincture, etc.). Preferred are calendula extract (particularly calendula oil), tea tree extract (leaf essential oil), Houtyami extract (particularly leaf tincture, extract), and adlay extract (fruit extract, tincture, etc.), and particularly preferred are It's calendula oil. For the purpose of adjusting the active ingredient concentration, it is possible to add a small amount of ginger extract.
これらの植物抽出物は、公知の方法に従って調製してもよいが、株式会社生活の木、ナチュラスサイコス(ハーバルインデックス有限会社)、株式会社ニールズヤードレメディーズ等から購入することができる。 These plant extracts may be prepared according to known methods, and can be purchased from Tree of Life Co., Ltd., Naturas Psychos (Herbal Index Co., Ltd.), Neal's Yard Remedies Co., Ltd., and the like.
殺菌剤又は防腐剤としては、安息香酸、デヒドロ酢酸、フェニルエタノール、フェノキシイソプロピルアルコール、ヒドロキシ安息香酸エステル類、クロルクレゾール、塩化ベンザルコニウム、塩化ベンゼトニウム、クロルヘキシジン、プロピレングリコール、パラオキシ安息香酸エステル、ソルビテン酸、チモール等を挙げることができる。 As disinfectants or preservatives, benzoic acid, dehydroacetic acid, phenylethanol, phenoxyisopropyl alcohol, hydroxybenzoic acid esters, chlorcresol, benzalkonium chloride, benzethonium chloride, chlorhexidine, propylene glycol, paraoxybenzoic acid ester, sorbitic acid , thymol and the like.
酸化防止剤としては、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、アルブチン、コウジ酸、エラグ酸、ルシノール、ビタミンC及びその誘導体、リノール酸等を挙げることができる。 Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, arbutin, kojic acid, ellagic acid, rucinol, vitamin C and its derivatives, linoleic acid, and the like.
乾姜以外の植物抽出物の含有量は、抽出物が乾燥エキスの場合には、外用剤全体の量を100重量%とした場合、当該乾燥エキスが0.001~5重量%の範囲で含まれればよく、当該乾燥エキスの含有量の下限値として、好ましくは0.01重量%、より好ましくは0.05重量%である。当該乾燥エキスの含有量の上限として、好ましくは2重量%、より好ましくは1重量%である。 When the extract is a dried extract, the content of plant extracts other than dried ginger is in the range of 0.001 to 5% by weight, when the total amount of the external preparation is 100% by weight. The lower limit of the content of the dry extract is preferably 0.01% by weight, more preferably 0.05% by weight. The upper limit of the content of the dry extract is preferably 2% by weight, more preferably 1% by weight.
乾姜以外の植物抽出物が、浸出油の場合には、外用剤全体の量を100容量とした場合、当該植物抽出物が5~50容量の範囲で含まれればよく、含有量は剤形の形状を維持できる範囲において調製することができる。当該植物浸出油の含有量の下限値として、好ましくは20容量である。当該植物抽出物の含有量の上限として、好ましくは50容量である。 If the plant extract other than dried ginger is infused oil, it is sufficient that the plant extract is contained in a range of 5 to 50 volumes when the total volume of the external preparation is 100 volumes, and the content depends on the dosage form. It can be prepared within a range that can maintain its shape. The lower limit of the content of the vegetable infused oil is preferably 20 volumes. The upper limit of the content of the plant extract is preferably 50 volumes.
乾姜以外の植物抽出物が、精油の場合には、外用剤全体の量を100容量とした場合、当該植物抽出物が0.01~1容量の範囲で含まれればよく、含有量は剤形の形状を維持できる範囲において調製することができる。当該植物浸出油の含有量の下限値として、好ましくは0.1容量である。当該植物抽出物の含有量の上限として、好ましくは0.3容量である。 If the plant extract other than dried ginger is an essential oil, it is sufficient that the plant extract is contained in the range of 0.01 to 1 volume when the total volume of the external preparation is 100 volumes; It can be prepared within a range that can maintain its shape. The lower limit of the content of the vegetable infused oil is preferably 0.1 volume. The upper limit of the content of the plant extract is preferably 0.3 volume.
このほかに添加剤として、紫外線吸収剤(パラアミノ安息香酸及びその誘導体、ケイ皮酸及びその誘導体、ベンゾフェノン及びその誘導体、サリチル酸及びその誘導体等)、紫外線散乱剤(酸化チタン、酸化亜鉛等)、生体成分(コラーゲン、ヒアルロン酸、セラミド、ホルモン、胎盤抽出物等)を含んでいてもよい。 In addition, additives include ultraviolet absorbers (para-aminobenzoic acid and its derivatives, cinnamic acid and its derivatives, benzophenone and its derivatives, salicylic acid and its derivatives, etc.), ultraviolet scattering agents (titanium oxide, zinc oxide, etc.), It may contain ingredients (collagen, hyaluronic acid, ceramide, hormones, placenta extract, etc.).
また、本発明の外用剤には、必要に応じて色材や香料(ローズ、ゼラニューム、ラベンダー、ハッカ、レモン、ネロリ、グレープフルーツ、オレンジ等の精油等)、pH調整剤(リン酸、クエン酸、クエン酸ナトリウム、乳酸、ジイソプロパノールアミン、酢酸、酢酸ナトリウム、コハク酸、コハク酸ナトリウム、リンゴ酸、リンゴ酸ナトリウム等)を添加してもよい。 In addition, the external preparation of the present invention may include colorants and fragrances (essential oils such as rose, geranium, lavender, peppermint, lemon, neroli, grapefruit, orange, etc.), pH regulators (phosphoric acid, citric acid, (sodium citrate, lactic acid, diisopropanolamine, acetic acid, sodium acetate, succinic acid, sodium succinate, malic acid, sodium malate, etc.) may be added.
殺菌剤、防腐剤、酸化防止剤、紫外線吸収剤、生体成分等の添加剤は、外用剤の0.00001~10重量%の範囲の間で適宜添加することができる。
各剤形の基剤に含まれる各原料の含有量は、調製しようとする剤形を維持できる範囲において適宜設定することができる。
Additives such as bactericides, preservatives, antioxidants, ultraviolet absorbers, and biological components can be added as appropriate in the range of 0.00001 to 10% by weight of the external preparation.
The content of each raw material contained in the base of each dosage form can be appropriately set within a range that maintains the dosage form to be prepared.
2.外用剤の調製方法
本発明の外用剤は、公知の方法等によって調製することができる。例えば、本発明の抽出液を約60~80℃加熱して、上記原料あるいはその他の抽出物を加えて5~10分程度混合し、ビタミンE化合物、精油等の添加剤を加えて撹拌後、不溶物等を濾過すれば液剤を得ることができる。ミツロウなどの高融点基材を加えておけば、冷却後にクリームなどの形態の外用組成物を調整可能である。
2. Method for Preparing External Preparation The external preparation of the present invention can be prepared by known methods. For example, heat the extract of the present invention at about 60 to 80°C, add the above raw materials or other extracts, mix for about 5 to 10 minutes, add additives such as vitamin E compound and essential oil, and stir. A liquid preparation can be obtained by filtering out insoluble matters. If a high melting point base material such as beeswax is added, it is possible to prepare an external composition in the form of a cream or the like after cooling.
3.外用剤の用途及び治療方法
本発明の外用剤は、医薬品、医薬部外品、化粧品として使用することができる。ここで、化粧品には、「医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律」に規定される薬用化粧品(有効成分が配合された化粧品)が含まれる。
3. Application of external preparation and treatment method The external preparation of the present invention can be used as a pharmaceutical, a quasi-drug, or a cosmetic. Here, cosmetics include medicated cosmetics (cosmetics containing active ingredients) defined in the "Act on Assuring the Quality, Efficacy, and Safety of Pharmaceuticals, Medical Devices, etc."
本発明の外用剤は、ショウガの含有成分による神経細胞保護作用等による疼痛緩和や、発熱・発汗・血流向上の作用による、保湿・皮膚機能の維持が期待される。 The external preparation of the present invention is expected to alleviate pain due to the nerve cell protective effect of the ingredients contained in ginger, and maintain moisturizing and skin functions due to the effects of increasing heat generation, sweating, and blood flow.
以下本発明の実施例を示すが、本発明は以下の実施例に限定されるものではない。 Examples of the present invention will be shown below, but the present invention is not limited to the following examples.
外用剤の調製
以下に記載の実施例1~4、および比較例1~2に従い外用剤の配合を行った。使用した乾姜は漢方薬局、ゴマ油はサミット精油(株)より購入した。トコフェロールおよび各種精油類は、一般的に化粧品原料として市販されているものを購入した。
Preparation of external preparations External preparations were formulated according to Examples 1 to 4 and Comparative Examples 1 to 2 described below. The dried ginger used was purchased from a Chinese herbal medicine pharmacy, and the sesame oil used was purchased from Summit Essential Oil Co., Ltd. Tocopherol and various essential oils were purchased from commercially available raw materials for cosmetics.
実施例1
ゴマ油100gを80℃で30分予備加熱を行った。その後加熱を止め、乾姜粉末1gを加え、自然放冷を行いながら24時間放置した。得られた抽出液にトコフェロール0.3gを加え、室温で10分撹拌し溶解させた。溶解後、1μmの粒子をカットできるフィルターで抽残渣を除去し外用剤1を得た。得られた外用剤1のショウガ由来成分の含有量を(財)日本食品分析センターに委託して高速液体クロマトグラフィーにより分析した。その結果、6-ショウガオールの濃度は17ppmであった。
Example 1
100 g of sesame oil was preheated at 80° C. for 30 minutes. Thereafter, the heating was stopped, 1 g of dried ginger powder was added, and the mixture was left to cool naturally for 24 hours. 0.3 g of tocopherol was added to the obtained extract and stirred at room temperature for 10 minutes to dissolve. After dissolution, the raffinate residue was removed using a filter capable of cutting particles of 1 μm to obtain
実施例2
ゴマ油100gを80℃で30分予備加熱を行った。その後加熱を止め、乾姜粉末10gを加え、自然放冷を行いながら24時間放置した。この抽出液にトコフェロール0.3gを加え、室温で10分撹拌し溶解させた。溶解後、1μmの粒子をカットできるフィルターで抽残渣を除去し外用剤2を得た。得られた外用剤2の6-ショウガオールの濃度は77ppmであった。
Example 2
100 g of sesame oil was preheated at 80° C. for 30 minutes. Thereafter, the heating was stopped, 10 g of dried ginger powder was added, and the mixture was left to cool naturally for 24 hours. To this extract, 0.3 g of tocopherol was added and stirred at room temperature for 10 minutes to dissolve. After dissolution, the raffinate residue was removed using a filter capable of cutting particles of 1 μm to obtain external preparation 2. The concentration of 6-shogaol in the obtained external preparation 2 was 77 ppm.
実施例3
ゴマ油100gを80℃で30分予備加熱を行った。その後加熱を止め、乾姜粉末3gを加え、自然放冷を行いながら24時間放置した。この抽出液にトコフェロール0.3gを加え、室温で10分撹拌し溶解させた。溶解後、1μmの粒子をカットできるフィルターで抽残渣を除去し外用剤3を得た。得られた外用剤3の6-ショウガオールの濃度は35ppmであった。
Example 3
100 g of sesame oil was preheated at 80° C. for 30 minutes. Thereafter, the heating was stopped, 3 g of dried ginger powder was added, and the mixture was left to cool naturally for 24 hours. To this extract, 0.3 g of tocopherol was added and stirred at room temperature for 10 minutes to dissolve. After dissolution, the raffinate residue was removed using a filter capable of cutting particles of 1 μm to obtain
実施例4
実施例3で得られた外用剤2を100g、ガラス容器に入れ、シアバター15gとミツロウ15gを加え、加熱して70℃で10分程攪拌し、シアバターとミツロウを完全溶解させたあと冷却し、クリーム状の外用剤4を得た。得られた外用剤4の6-ショウガオールの濃度は60ppmであった。
Example 4
Put 100 g of the external preparation 2 obtained in Example 3 into a glass container, add 15 g of shea butter and 15 g of beeswax, heat and stir at 70°C for about 10 minutes to completely dissolve the shea butter and beeswax, then cool. A cream-like external preparation 4 was obtained. The concentration of 6-shogaol in the obtained external preparation 4 was 60 ppm.
比較例1
ゴマ油100gを80℃で30分予備加熱を行った。市販のショウガ精油(株式会社インセント製)を0.1g添加し、比較剤1とした。
Comparative example 1
100 g of sesame oil was preheated at 80° C. for 30 minutes.
比較例2
ゴマ油100gを80℃で30分予備加熱を行った。市販のショウガ精油(株式会社インセント製)を0.5g添加し、比較剤2とした。
各外用組成物の構成を図1に示す。
評価方法
Comparative example 2
100 g of sesame oil was preheated at 80° C. for 30 minutes. Comparative agent 2 was prepared by adding 0.5 g of commercially available ginger essential oil (manufactured by Incent Co., Ltd.).
The composition of each external composition is shown in FIG.
Evaluation method
ボランティア5名に実施例1~5および比較例1~2の外用剤を疼痛部に外用してもらい、温かく感じるか(温感)と疼痛の緩和効果、および使用後の臭気があるかについてアンケートを行った。その結果、実施例1については、5名中3名が効果を感じると回答し、2名は効果を感じないと回答した。実施例2~5については全員が効果を感じると回答した。使用後の臭気については、実施例1~5すべてに対して、“臭いはない”または“気にならない”と回答した。一方比較例1~2については、全員が効果を感じず、使用後に強い刺激臭があると回答した。
評価の結果を図2に示す。
Five volunteers were asked to apply the topical preparations of Examples 1 to 5 and Comparative Examples 1 to 2 on the painful area, and a questionnaire was conducted regarding whether they felt warm (warm sensation), pain relief effects, and whether there was an odor after use. I did it. As a result, for Example 1, 3 out of 5 people answered that they felt it was effective, and 2 people answered that they felt no effect. Regarding Examples 2 to 5, all respondents answered that they felt the effects. Regarding the odor after use, for all Examples 1 to 5, respondents answered that there was no odor or that it did not bother them. On the other hand, for Comparative Examples 1 and 2, all respondents answered that they did not feel any effect and that there was a strong irritating odor after use.
The results of the evaluation are shown in Figure 2.
今回の評価の結果について、その効果を単一の成分に帰属させるのは困難であるが、発明者らは6-ショウガオールが有効成分の一つであると考えている。したがって、抽出において6-ショウガオールの濃度を管理対象としている。本発明の抽出方法は、刺激臭の元になる成分が相対的にかなり少ないことが特徴であり、そのためか外用時の副反応はなく臭気も気にならないレベルであった。臭気が少ないため、他の精油類を添加することで外用剤の匂いを調整可能である。また基材が親油性であるため皮膚への浸透が速いためか、効果に即効性があった。
Regarding the results of this evaluation, although it is difficult to attribute the effect to a single ingredient, the inventors believe that 6-shogaol is one of the active ingredients. Therefore, the concentration of 6-shogaol is controlled during extraction. The extraction method of the present invention is characterized by a relatively small amount of components that cause irritating odors, and perhaps because of this, there were no side reactions during external use and the odor was at a level that was not bothersome. Because it has little odor, the odor of external preparations can be adjusted by adding other essential oils. In addition, the effect was immediate, probably because the base material is lipophilic and penetrates into the skin quickly.
Claims (2)
A topical preparation containing 50% by weight or more of an extract characterized by extracting dried ginger (dried ginger) powder using non-roasted sesame oil and removing the extracted dried ginger powder by filtration. , an external preparation for pain relief characterized by containing 10 to 200 ppm of 6-shogaol
The external cream according to claim 1, characterized in that it contains shea butter.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023087352A JP7398589B1 (en) | 2023-05-28 | 2023-05-28 | External pain relief preparation containing ginger ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023087352A JP7398589B1 (en) | 2023-05-28 | 2023-05-28 | External pain relief preparation containing ginger ingredients |
Publications (1)
Publication Number | Publication Date |
---|---|
JP7398589B1 true JP7398589B1 (en) | 2023-12-14 |
Family
ID=89117015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023087352A Active JP7398589B1 (en) | 2023-05-28 | 2023-05-28 | External pain relief preparation containing ginger ingredients |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7398589B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007210993A (en) * | 2005-10-26 | 2007-08-23 | Oriza Yuka Kk | Anti-inflammatory agent |
JP2013147436A (en) * | 2012-01-17 | 2013-08-01 | Nla:Kk | Arthralgia alleviating composition, and functional food |
WO2015170681A1 (en) * | 2014-05-09 | 2015-11-12 | サントリーホールディングス株式会社 | Fat or oil extract of black ginger and method for producing same |
JP2015214519A (en) * | 2014-05-13 | 2015-12-03 | 株式会社 セニルラボラトリーズ | External preparation for skin |
CN106620617A (en) * | 2016-12-30 | 2017-05-10 | 李淑娟 | Medicinal oil capable of removing dampness and eliminating toxin |
JP2019073448A (en) * | 2017-10-12 | 2019-05-16 | 国立大学法人大阪大学 | External preparation for protecting melanocyte |
-
2023
- 2023-05-28 JP JP2023087352A patent/JP7398589B1/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007210993A (en) * | 2005-10-26 | 2007-08-23 | Oriza Yuka Kk | Anti-inflammatory agent |
JP2013147436A (en) * | 2012-01-17 | 2013-08-01 | Nla:Kk | Arthralgia alleviating composition, and functional food |
WO2015170681A1 (en) * | 2014-05-09 | 2015-11-12 | サントリーホールディングス株式会社 | Fat or oil extract of black ginger and method for producing same |
JP2015214519A (en) * | 2014-05-13 | 2015-12-03 | 株式会社 セニルラボラトリーズ | External preparation for skin |
CN106620617A (en) * | 2016-12-30 | 2017-05-10 | 李淑娟 | Medicinal oil capable of removing dampness and eliminating toxin |
JP2019073448A (en) * | 2017-10-12 | 2019-05-16 | 国立大学法人大阪大学 | External preparation for protecting melanocyte |
Non-Patent Citations (2)
Title |
---|
SRINIVASAN, Krishnapura,Ginger rhizomes (Zingiber officinale): A spice with multiple health beneficial potentials,Pharma Nutrition,2017年,Volume 5, Issue 1,Pages 18-28 |
SRINIVASAN, KRISHNAPURA: "Ginger rhizomes (Zingiber officinale): A spice with multiple health beneficial potentials", PHARMA NUTRITION, vol. Volume 5, Issue 1, JPN6023033219, 2017, pages 18 - 28, ISSN: 0005146591 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1304115B1 (en) | Antipruritic compositions and compositions promoting wound healing | |
US8968755B2 (en) | Topical base and active agent-containing compositions, and methods for improving and treating skin | |
KR102257342B1 (en) | Composition for antimicrobial and anti-inflammatory activities and manufacturing method thereof | |
US20190021961A1 (en) | Water-in-oil emulsion | |
KR101913808B1 (en) | Cosmetic composition comprising dry flower for skin moisture | |
KR101961608B1 (en) | Compositions comprising malkangni oil and cypriol oil for reducing pain | |
US10736836B2 (en) | Method of treating external tissues with waxes | |
AU2004222536B2 (en) | Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas | |
US10238596B1 (en) | Restorative formulations | |
MX2012001611A (en) | Topical medicament for the treatment of psoriasis. | |
US8383166B2 (en) | Stable hydrophobic topical herbal formulationn | |
JP7398589B1 (en) | External pain relief preparation containing ginger ingredients | |
US11478446B2 (en) | Pain relieving formulations containing cannabis and methods of making same | |
CN110420132B (en) | Whitening skin care composition and preparation method thereof | |
JP6175280B2 (en) | Composition for improving pores | |
JP2019073448A (en) | External preparation for protecting melanocyte | |
WO2020245569A1 (en) | Skin treatment composition | |
KR100892742B1 (en) | Skin external composition for treating pimple | |
JP6853406B1 (en) | Topical composition for antifolliculitis | |
KR101117371B1 (en) | Functional Cosmetic Composition Comprising Aroma Composition Having Appetite Suppression Effect And Manufacturing Method Thereof | |
US20120201915A1 (en) | Therapeutic composition | |
JP4783121B2 (en) | Cosmetics containing lavender oil and coenzyme Q | |
RU2202337C2 (en) | Cosmetic preparation for skin care (versions) | |
WO2024042452A1 (en) | Topical composition for pain relief | |
KR20240082798A (en) | Cosmetic composition for skin improvement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230719 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230719 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230905 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230915 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231128 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231204 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7398589 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |